Robot or scalpel? european trial tests less invasive pancreatic cancer surgery
NCT ID NCT04483726
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial compares two types of surgery for pancreatic cancer in the body or tail of the pancreas: minimally invasive (laparoscopic or robot-assisted) versus traditional open surgery. The goal is to see if the less invasive approach can remove the tumor just as completely. Adults with resectable pancreatic cancer who are fit for either surgery type may join.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
minimally invasive distal pancreatectomy (laparoscopic or robot-assisted)
What this could lead to
If minimally invasive surgery proves as effective as open surgery, it could offer patients a less painful recovery with similar cancer outcomes.
What could go wrong
This is a relatively small early-phase trial, so results may not be definitive. Minimally invasive surgery may not remove the tumor as completely as open surgery in some cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Saint Eloi - Montpellier
Montpellier, France
-
Centre Hospitalier Orléans
Orléans, France
-
Hôpital Beaujon - APHP
Clichy, France
-
Hôpital Paul Brousse
Villejuif, France
-
Institut Mutualiste Montsouris
Paris, France